Laboratory biomarkers associated with COVID-19 severity and management
- PMID: 33153974
- PMCID: PMC7581344
- DOI: 10.1016/j.clim.2020.108614
Laboratory biomarkers associated with COVID-19 severity and management
Abstract
The heterogeneous disease course of COVID-19 is unpredictable, ranging from mild self-limiting symptoms to cytokine storms, acute respiratory distress syndrome (ARDS), multi-organ failure and death. Identification of high-risk cases will enable appropriate intervention and escalation. This study investigates the routine laboratory tests and cytokines implicated in COVID-19 for their potential application as biomarkers of disease severity, respiratory failure and need of higher-level care. From analysis of 203 samples, CRP, IL-6, IL-10 and LDH were most strongly correlated with the WHO ordinal scale of illness severity, the fraction of inspired oxygen delivery, radiological evidence of ARDS and level of respiratory support (p ≤ 0.001). IL-6 levels of ≥3.27 pg/ml provide a sensitivity of 0.87 and specificity of 0.64 for a requirement of ventilation, and a CRP of ≥37 mg/l of 0.91 and 0.66. Reliable stratification of high-risk cases has significant implications on patient triage, resource management and potentially the initiation of novel therapies in severe patients.
Keywords: Biomarkers; COVID-19; CRP; Cytokines; IL-10; IL-6; Intensive care; LDH.
Crown Copyright © 2020. Published by Elsevier Inc. All rights reserved.
Conflict of interest statement
None.
Figures
Similar articles
-
Double-blind, randomized, controlled, trial to assess the efficacy of allogenic mesenchymal stromal cells in patients with acute respiratory distress syndrome due to COVID-19 (COVID-AT): A structured summary of a study protocol for a randomised controlled trial.Trials. 2021 Jan 6;22(1):9. doi: 10.1186/s13063-020-04964-1. Trials. 2021. PMID: 33407777 Free PMC article.
-
Clinical characteristics of Egyptian male patients with COVID-19 acute respiratory distress syndrome.PLoS One. 2021 Apr 16;16(4):e0249346. doi: 10.1371/journal.pone.0249346. eCollection 2021. PLoS One. 2021. PMID: 33861750 Free PMC article.
-
Basic Predictive Risk Factors for Cytokine Storms in COVID-19 Patients.Front Immunol. 2021 Nov 10;12:745515. doi: 10.3389/fimmu.2021.745515. eCollection 2021. Front Immunol. 2021. PMID: 34858403 Free PMC article.
-
Predictive monitoring and therapeutic immune biomarkers in the management of clinical complications of COVID-19.Cytokine Growth Factor Rev. 2021 Apr;58:32-48. doi: 10.1016/j.cytogfr.2020.10.002. Epub 2020 Oct 9. Cytokine Growth Factor Rev. 2021. PMID: 33199179 Free PMC article. Review.
-
Acute respiratory distress syndrome (ARDS) caused by the novel coronavirus disease (COVID-19): a practical comprehensive literature review.Expert Rev Respir Med. 2021 Feb;15(2):183-195. doi: 10.1080/17476348.2020.1820329. Epub 2020 Oct 18. Expert Rev Respir Med. 2021. PMID: 32902367 Review.
Cited by
-
Effect of dexamethasone in patients with ARDS and COVID-19 (REMED trial)-study protocol for a prospective, multi-centre, open-label, parallel-group, randomized controlled trial.Trials. 2022 Jan 15;23(1):35. doi: 10.1186/s13063-021-05963-6. Trials. 2022. PMID: 35033182 Free PMC article.
-
LENZILUMAB EFFICACY AND SAFETY IN NEWLY HOSPITALIZED COVID-19 SUBJECTS: RESULTS FROM THE LIVE-AIR PHASE 3 RANDOMIZED DOUBLE-BLIND PLACEBO-CONTROLLED TRIAL.medRxiv [Preprint]. 2021 May 5:2021.05.01.21256470. doi: 10.1101/2021.05.01.21256470. medRxiv. 2021. PMID: 33972949 Free PMC article. Preprint.
-
C-reactive protein: structure, function, regulation, and role in clinical diseases.Front Immunol. 2024 Jun 14;15:1425168. doi: 10.3389/fimmu.2024.1425168. eCollection 2024. Front Immunol. 2024. PMID: 38947332 Free PMC article. Review.
-
Serum Total Antioxidant Capacity (TAC) and TAC/Lymphocyte Ratio as Promising Predictive Markers in COVID-19.Int J Mol Sci. 2023 Aug 18;24(16):12935. doi: 10.3390/ijms241612935. Int J Mol Sci. 2023. PMID: 37629114 Free PMC article.
-
Common hematological values predict unfavorable outcomes in hospitalized COVID-19 patients.Clin Immunol. 2021 Apr;225:108682. doi: 10.1016/j.clim.2021.108682. Epub 2021 Feb 4. Clin Immunol. 2021. PMID: 33549831 Free PMC article.
References
-
- ICNARC . 2020. ICNARC Report on COVID-19 in Critical Care. London.
-
- European center for disease prevention and control . 2020. Rapid Risk Assessment - Coronavirus Disease 2019 COVID-19 in the EU/EEA and the UK – Eighth Update.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous